Putative mechanisms behind effects of spinal cord stimulation on vascular diseases: a review of experimental studies.
Spinal cord stimulation (SCS) is a widely used clinical technique to treat ischemic pain in peripheral, cardiac and cerebral vascular diseases. The use of this treatment advanced rapidly during the late 80's and 90's, particularly in Europe. Although the clinical benefits of SCS are clear and the success rate remains high, the mechanisms are not yet completely understood. SCS at lumbar spinal segments (L2-L3) produces vasodilation in the lower limbs and feet which is mediated by antidromic activation of sensory fibers and decreased sympathetic outflow. SCS at thoracic spinal segments (T1-T2) induces several benefits including pain relief, reduction in both frequency and severity of angina attacks, and reduced short-acting nitrate intake. The benefits to the heart are not likely due to an increase, or redistribution of local blood flow, rather, they are associated with SCS-induced myocardial protection and normalization of the intrinsic cardiac nervous system. At somewhat lower cervical levels (C3-C6), SCS induces increased blood flow in the upper extremities. SCS at the upper cervical spinal segments (C1-C2) increased cerebral blood flow, which is associated with a decrease in sympathetic activity, an increase in vasomotor center activity and a release of neurohumoral factors. This review will summarize the basic science studies that have contributed to our understanding about mechanisms through which SCS produces beneficial effects when used in the treatment of vascular diseases. Furthermore, this review will particularly focus on the antidromic mechanisms of SCS-induced vasodilation in the lower limbs and feet.
Wu
Mingyuan
M
Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, OK 73190, United States. mingyuan-wu@ouhsc.edu
Linderoth
Bengt
B
Foreman
Robert D
RD
D000818:Animals; D001808:Blood Vessels / Q000294:innervation / Q000503:physiopathology; D002545:Brain Ischemia / Q000503:physiopathology / Q000628:therapy; D004599:Electric Stimulation Therapy / Q000379:methods*; D006801:Humans; D007511:Ischemia / Q000503:physiopathology* / Q000628:therapy*; D017202:Myocardial Ischemia / Q000503:physiopathology / Q000628:therapy; D010148:Intractable Pain / Q000209:etiology / Q000503:physiopathology* / Q000628:therapy*; D011984:Sensory Receptor Cells / Q000503:physiopathology; D013116:Spinal Cord / Q000503:physiopathology*; D013564:Sympathetic Nervous System / Q000503:physiopathology